Back to top

TD Cowen says arbitration decision removes overhang for Prime Medicine’s PM647

TD Cowen notes that Prime Medicine (PRME) announced a positive binding arbitration resolution with Beam Therapeutics (BEAM) over PM647 in alpha-1 a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Beam Therapeutics Inc. (BEAM)

Prime Medicine, Inc. (PRME)